biotech / news / / The News International
OpenAI launches GPT-Rosalind, a new model for biology, drug discovery, and translational medicine.
OpenAI launched GPT-Rosalind, its first domain-specific model for biology and drug discovery tasks.
KEY POINTS
- GPT-Rosalind achieved the highest BixBench score yet, surpassing all other published models.
- Access to GPT-Rosalind is restricted to qualified US enterprise customers following safety reviews.
- Launch partners include Amgen, Moderna, and Thermo Fisher, with separate research with Los Alamos National Laboratory.
- A free Life Sciences research plugin for Codex is available, linking to over 50 scientific databases.
COMPANIES
Summarized by Newsio from The News International. How we summarize →